| 生物活性 | |||
|---|---|---|---|
| 靶点 | 
 | ||
| 描述 | CNX-774, an orally active, irreversible, and selective BTK inhibitor with an IC50 of <1 nM, specifically targets Cysteine 481 of Btk for covalent modification [1][2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.00mL 0.40mL 0.20mL | 10.01mL 2.00mL 1.00mL | 20.02mL 4.00mL 2.00mL | 
| 参考文献 | 
|---|